Ghent University Academic Bibliography

Journal Article
A1
open access

A phase I, first-in-human, dose-escalation, expansion trial of cytokine-encoding synthetic mRNA mixture alone or with cemiplimab in advanced solid tumors

Oliver Bechter, Carmen Loquai, Stephane Champiat, Jean-Francois Baurain, Jean-Jacques Grob, Jochen Utikal, Sylvie Rottey (UGent) , Alfonso Berrocal, Jessica C Hassel, Ana Arance, et al.

(2025) CLINICAL CANCER RESEARCH. 31(12). p.2358-2369

Add to list

Journal Article
A1
open access

Safety and efficacy of tarlatamab in patients with neuroendocrine prostate cancer : results from the Phase 1b DeLLpro-300 study

Rahul Aggarwal, Sylvie Rottey (UGent) , Alice Bernard-Tessier, Begoña Mellado, Takeo Kosaka, Walter M Stadler, Lisa Horvath, Richard Greil, Bert O'Neil, Bilal A Siddiqui, et al.

(2025) CLINICAL CANCER RESEARCH. 31(18). p.3854-3863

Add to list

A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer

Tanya Dorff, Lisa G. Horvath, Karen Autio, Alice Bernard-Tessier, Matthew B. Rettig, Jean-Pascal Machiels, Mehmet A. Bilen, Martijn P. Lolkema, Nabil Adra, Sylvie Rottey (UGent) , et al.

(2024) CLINICAL CANCER RESEARCH. 30(8). p.1488-1500

Add to list

Journal Article
A1
open access

Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement

Darrell Green, Roelof van Ewijk, Elisa Tirtei, Dimosthenis Andreou, Fredrik Baecklund, Daniel Baumhoer, Stefan S. Bielack, Rajesh Botchu, Kjetil Boye, Bernadette Brennan, et al.

(2024) CLINICAL CANCER RESEARCH. 30(16). p.3395-3406

Add to list

Journal Article
A1
open access

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

Sara M. Tolaney, Shom Goel, Jorge Nadal, Hannelore Denys (UGent) , Manuel R. Borrego, Lacey M. Litchfield, Jiangang Liu, Adams K. Appiah, Yanyun Chen and Fabrice André

(2024) CLINICAL CANCER RESEARCH. 30(1). p.39-49

Add to list

Journal Article
A1
open access

KLRG1 cell depletion as a novel therapeutic strategy in patients with mature T-cell lymphoma subtypes

Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Kusha Chopra, Sung Rye Park, Michael Yevgeniy Tolstorukov, Sean M. McCabe, Jessica Duffy, et al.

(2024) CLINICAL CANCER RESEARCH. 30(11). p.2514-2530

Add to list

Journal Article
A1
open access

Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions

Audrey-Anne Lamoureux, Michael J. Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Christof Kramm, Bram De Wilde (UGent) , Bernarda Kazanowska, Caroline Hutter, Stefan M. Pfister, et al.

(2024) CLINICAL CANCER RESEARCH. 31(3). p.561-572

Add to list

Journal Article
A1
open access

ENIGMA CHEK2gether Project : a comprehensive study identifies functionally impaired CHEK2 germline missense variants associated with increased breast cancer risk

Lenka Stolarova, Petra Kleiblova, Petra Zemankova, Barbora Stastna, Marketa Janatova, Jana Soukupova, Maria Isabel Achatz, Christine Ambrosone, Paraskevi Apostolou, Banu K. Arun, et al.

(2023) CLINICAL CANCER RESEARCH. 29(16). p.3037-3050

Add to list

Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial

Raphael Koch, Lianne Haveman, Ruth Ladenstein, Benedicte Brichard, Heribert Jürgens, Sona Cyprova, Henk van den Berg, Wolf Hassenpflug, Anna Raciborska, Torben Ek, et al.

(2023) CLINICAL CANCER RESEARCH. 29(24). p.5057-5068

Add to list

Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis

Teresa González-Muñoz, Angela Di Giannatale, Susana García-Silva, Vanesa Santos, Sara Sánchez-Redondo, Claudia Savini, Osvaldo Graña-Castro, Carmen Blanco-Aparicio, Suzanne Fischer (UGent) , Olivier De Wever (UGent) , et al.

(2023) CLINICAL CANCER RESEARCH. 29(18). p.3744-3758

Academic Bibliography

A phase I, first-in-human, dose-escalation, expansion trial of cytokine-encoding synthetic mRNA mixture alone or with cemiplimab in advanced solid tumors

Safety and efficacy of tarlatamab in patients with neuroendocrine prostate cancer : results from the Phase 1b DeLLpro-300 study

A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer

Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement

Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients

KLRG1 cell depletion as a novel therapeutic strategy in patients with mature T-cell lymphoma subtypes

Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions

ENIGMA CHEK2gether Project : a comprehensive study identifies functionally impaired CHEK2 germline missense variants associated with increased breast cancer risk

Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial

Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis

Contents

Support

Contact